Double-staining of CD68+/Rep+ cells was detected in 1.8% interstitial cells in cancer-free patients compared to 7.3% in cancer patients, which matches the values for Rep-positivity alone (Fig. 3E). This evidence concerns the gene CD68 and cancer.